Date post: | 08-Sep-2014 |
Category: |
Health & Medicine |
Upload: | gds-international |
View: | 10 times |
Download: | 3 times |
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
World AIDS Day
Status of the Global Epidemic
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
AIDS was first recognised in 1981 in the US
Genetic research indicates that HIV originated in Africa during the late 1800s and is thought to have arrivedinto the Western Hemisphere from Haiti in the late 1960s.
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Since then the prevalence of AIDS has increaseddramatically...
33.4 million people are living with HIV worldwide
2.1 million are children under 15
There were 2.7 million new cases of HIV in 2008
2 million people died from HIV and AIDS in 2008
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Since its initial recognition AIDS is believed to have killed
25 million people
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Sub-Saharan Africa22 million
Asia5 million
People living with HIV around the world
Latin America1.7 million
Middle East and North Africa
380,000
Oceania74,000
Eastern Europeand Central Asia
1.5 million
N.Americaand West Europe
2 million
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Number of new cases in 2007
Sub-Saharan Africa1.9 million
Asia380,000
Eastern Europe and Central Asia
110,000
Latin America140,000
N.America andWest Europe
81,000
Middle East andNorth Africa
40,000
Oceania13,000
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Sub-Saharan Africa remains the region most heavily affected by HIV
67% of those living with HIV live in Sub-Saharan Africa
75% of AIDS deaths occurin Sub-Saharan Africa
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
The number of children living with HIV has been steadily increasing
1990: 250,000 children2000: 1,450,000 children2007: 2,100,000 children
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
There were over 7,400 new HIV infections a day in 2008
1200 cases were children
48% werewomen
97% were in low and middle income
countries
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Total annual resources available for AIDS
$8.9 billion2007
EC 0.5%
UN 2%
Global Fund 7%
Foundations 6%
Bilaterals 33%Domestic Public & Private 52%
In 1987 total resourcesequalled just $59 million
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Total annual resources available for AIDS
Foundations 6%
Treatment is becoming more universal, with coverage doubling in 2 years
15%had access to antiretrovial
therapy in 2005
33%had access to antiretrovial
therapy in 2007
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
The world currently possesses the means to prevent new HIV infections, reduce HIV-related illness and death, and mitigate the epidemic’s harmful effects on households, communities, and societies.
Yet, there is no annual research update on the subject andthe National Institutes of Health, perhaps the best hope of curing AIDS, has been underfunded for almost a decade.
A cure for AIDS could save the lives of millions of people around the world. Too many lives have been lost and devastated already.
Next Generation Pharmaceutical EUwww.ngpharma.eu.com
Further Reading
www.unaids.orgwww.worldaidsday.orghttp://www.philly.com/inquirer/opinion/20091201_AIDS_cure_isn_t_out_of_reach.html